Stride Therapeutics

Investment area
Novo Ventures
Region
North America
Date of investment
April 2021
StrideBio is a product-driven, fully integrated gene therapy company focused on creating and developing innovative genetic medicines with life-changing or curative potential for patients with devastating conditions, including monogenic rare disease and beyond.

Stride Therapeutics

Investment area
Novo Ventures
Region
North America
Date of investment
April 2021
StrideBio is a product-driven, fully integrated gene therapy company focused on creating and developing innovative genetic medicines with life-changing or curative potential for patients with devastating conditions, including monogenic rare disease and beyond.

Stride Therapeutics

Investment area
Novo Ventures
Region
North America
Date of investment
April 2021
StrideBio is a product-driven, fully integrated gene therapy company focused on creating and developing innovative genetic medicines with life-changing or curative potential for patients with devastating conditions, including monogenic rare disease and beyond.